1/16
07:20 am
nthi
Neonc Technologies (NASDAQ:NTHI) was upgraded by analysts at Zacks Research to a "hold" rating.
Low
Report
Neonc Technologies (NASDAQ:NTHI) was upgraded by analysts at Zacks Research to a "hold" rating.
1/10
07:02 pm
nthi
Stonegate Capital Partners Initiates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) [Yahoo! Finance]
Low
Report
Stonegate Capital Partners Initiates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) [Yahoo! Finance]
1/4
03:39 pm
nthi
New to The Street Airs Tonight on Bloomberg Television - Show No. 712 Sponsored Programming Spotlighting Public and Private Market Innovators [Yahoo! Finance]
Medium
Report
New to The Street Airs Tonight on Bloomberg Television - Show No. 712 Sponsored Programming Spotlighting Public and Private Market Innovators [Yahoo! Finance]
12/20
06:34 pm
nthi
New to The Street Broadcasts Nationwide Tonight on Bloomberg Television Featuring NeOnc ($NTHI), Metaterra Holdings Inc., CISO Global ($CISO), and NRx Pharmaceuticals ($NRXP) [Yahoo! Finance]
Medium
Report
New to The Street Broadcasts Nationwide Tonight on Bloomberg Television Featuring NeOnc ($NTHI), Metaterra Holdings Inc., CISO Global ($CISO), and NRx Pharmaceuticals ($NRXP) [Yahoo! Finance]
12/15
09:49 am
nthi
NeOnc Technologies Reports Updated Clinical Results [Yahoo! Finance]
Medium
Report
NeOnc Technologies Reports Updated Clinical Results [Yahoo! Finance]
12/15
09:00 am
nthi
NeOnc Technologies Reports Updated Clinical Results
Medium
Report
NeOnc Technologies Reports Updated Clinical Results
12/1
09:13 am
nthi
NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors [Yahoo! Finance]
High
Report
NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors [Yahoo! Finance]
12/1
09:00 am
nthi
NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors
Medium
Report
NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors
11/14
07:08 pm
nthi
With 61% ownership, NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) insiders have a lot riding on the company's future [Yahoo! Finance]
High
Report
With 61% ownership, NeOnc Technologies Holdings, Inc. (NASDAQ:NTHI) insiders have a lot riding on the company's future [Yahoo! Finance]
11/14
05:41 pm
nthi
NeOnc Technologies Holdings GAAP EPS of -$0.45 [Seeking Alpha]
High
Report
NeOnc Technologies Holdings GAAP EPS of -$0.45 [Seeking Alpha]
11/14
04:01 pm
nthi
NeOnc Technologies Holdings Reports Third Quarter 2025 Results and Provides Operational Update
High
Report
NeOnc Technologies Holdings Reports Third Quarter 2025 Results and Provides Operational Update
11/13
09:00 am
nthi
NeOnc Technologies Completes Enrollment in Pivotal NEO100 Phase2a Trial for IDH-1 mutant Recurrent High-Grade Glioma and Expects Interim Data Readout in SixMonths (Q22026)
High
Report
NeOnc Technologies Completes Enrollment in Pivotal NEO100 Phase2a Trial for IDH-1 mutant Recurrent High-Grade Glioma and Expects Interim Data Readout in SixMonths (Q22026)
11/12
08:48 am
nthi
NeOnc Technologies Reports Updated Clinical Results [Yahoo! Finance]
Medium
Report
NeOnc Technologies Reports Updated Clinical Results [Yahoo! Finance]
11/12
08:00 am
nthi
NeOnc Technologies Reports Updated Clinical Results
Medium
Report
NeOnc Technologies Reports Updated Clinical Results
11/7
09:00 am
nthi
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program
Low
Report
NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program
11/4
09:00 am
nthi
NeOnc Technologies Appoints Amir Heshmatpour as Chief Executive Officer to Drive Next Phase of Clinical and Corporate Growth
Low
Report
NeOnc Technologies Appoints Amir Heshmatpour as Chief Executive Officer to Drive Next Phase of Clinical and Corporate Growth
10/28
09:00 am
nthi
His Highness Sheikh Nahyan bin Zayed Al Nahyan Assumes Executive Chairmanship of NeOnc Technologies' Subsidiary, NuroMENA, Pioneering UAE-US Partnership in Brain Cancer Treatment
High
Report
His Highness Sheikh Nahyan bin Zayed Al Nahyan Assumes Executive Chairmanship of NeOnc Technologies' Subsidiary, NuroMENA, Pioneering UAE-US Partnership in Brain Cancer Treatment